MedTrace Logo

Improving Work Outcome in People With Recent-onset Schizophrenia

NCT00203788 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2013-07-30

No results posted yet for this study

Summary

This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining work or school activities in people with recent-onset schizophrenia.

Conditions

Interventions

BEHAVIORAL

Individual Placement and Support

Supported education/employment

BEHAVIORAL

Workplace Fundamentals Module

Group skills training on job/school topics

BEHAVIORAL

Brokered Vocational Rehabilitation

Vocational rehabilitation through traditional separate state-funded agency

DRUG

Oral risperidone

Risperidone, starting target dosage was 6 mg, adjusted to level judged optimal by treating psychiatrist

BEHAVIORAL

Skills training group

Group social skills training that did not focus primarily on work situations

Sponsors & Collaborators

Principal Investigators

  • Keith H Nuechterlein, PhD · University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-05-31
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203788 on ClinicalTrials.gov